Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1): Structure-function relationships of RNA editing and dimerization

Journal of Lipid Research

Volumn 40, Issue 4, 1999, Pages 623-635

  Teng, Ba Bie ^a,b   Ochsner, Scott ^a   Zhang, Qian ^b   Soman, Kizhake V ^a,c   Lau, Paul P ^a   Chan, Lawrence ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

ApoB; APOBEC1; Cytidine deaminase; RNA editing

Indexed keywords

APOLIPOPROTEIN B; CYTIDINE DEAMINASE; MESSENGER RNA; MUTANT PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME MECHANISM; ENZYME SUBUNIT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; RNA EDITING; SITE DIRECTED MUTAGENESIS;

ANIMALS; APOLIPOPROTEINS B; BASE SEQUENCE; BINDING SITES; CATALYSIS; CYTIDINE DEAMINASE; DIMERIZATION; IMMUNOSORBENT TECHNIQUES; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; RATS; RNA EDITING; RNA, MESSENGER; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032958220     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Scott, J. 1995. A place in the world for RNA editing. Cell 81: 833-836.
2. Chan, L., B. H-J. Chang, M. Nakamuta, W-H. Li, and L. C. Smith. 1997. Apobec1 and apolipoprotein B mRNA editing. Biochim. Biophys. Acta. 1345: 11-26.
3. Powell, L. W., S. C. Wallis, R. J. Pease, Y. H. Edwards, T. J. Knott, and J. Scott. 1987. A novel form of tissue-specific RNA processing produces apolipoprotein B48 in intestine. Cell. 50: 831-840.
4. Chen, S-H., G. Habih, C-Y. Yang, Z-W. Gu, B. R. Lee, S-A. Weng, S. R. Silberman, S-J. Cai, J. P. Deslypere, M. Rosseneu, A. M. Gotto, Jr., W-H. Li, and L. Chan. 1987. Apolipoprotein B-48 is the product of a mRNA with an organ-specific in-frame stop codon. Science. 238: 363-366.
5. Chan, L. 1992. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoprotein. J. Biol. Chem. 267: 25621-25624.
6. Kane, J. P. 1983. Apolipoprotein B: structural and metabolic heterogeneity. Annu. Rev. Physiol. 45: 637-650.
7. Teng, B. B., C. F. Burant, and N. O. Davidson. 1993. Molecular cloning of an apoB mRNA editing protein. Science. 260: 1816-1819.
8. Davidson, N. O., T. L. Innerarity, J. Scott, H. Smith, D. M. Driscoll, B. B. Teng, and L. Chan. 1995. Proposed nomenclature for the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme: apobec1. RNA. 1: 3.
9. Navaratnam, N., J. R. Morrison, S. Bhattacharya, D. Patel, T. Funahashi, F. Giannon, B. B. Teng, N. O. Davidson, and J. Scott. 1993. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J. Biol. Chem. 268: 20709-20712.
10. Johnson, D. F., K. S. Poksay, and T. Innerarity. 1993. The mechanism for apoB mRNA editing is deamination. Biochem. Biophys. Res. Commun. 195: 1204-1210.
11. Driscoll, D. M., and Q. Zhang. 1994. Expression and characterization of p27, the catalytic subunit of the apolipoprotein B mRNA editing enzyme. J. Biol. Chem. 269: 19843-19847.
12. Giannoni, F., D. K. Bonen, T. Funahashi, C. Hadjiagapiou, C. F. Burant, and N. O. Davidson. 1994. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J. Biol. Chem. 269: 5932-5936.
13. Lau, P. P., H-J. Zhu, M. Nakamuta, and L. Chan. 1997. Cloning of an apobec1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J. Biol. Chem. 272: 1452-1455.
14. Mehta, A., S. Banerjee, and D. M. Driscoll. 1996. Apobec1 interacts with a 65-kDa complementing protein to edit apolipoprotein B mRNA in vitro. J. Biol. Chem. 271: 28294-28299.
15. Teng, B. B., and N. O. Davidson. 1992. Evolution of intestinal apolipoprotein B mRNA editing: chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s). J. Biol. Chem. 269: 21265-21272.
16. Yamanaka, S., K. S. Poksay, M. E. Balestra, G-Q. Zeng, and T. L. Innerarity. 1994. Cloning and mutagenesis of the rabbit apoB mRNA editing protein. J. Biol. Chem. 269: 21725-21734.
17. Schock, D., S-R. Kuo, M. F. Steinburg, M. Bolognino, J. D. Sparks, C. Sparks, and H. C. Smith. 1996. An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B mRNA editing. Proc. Natl. Acad. Sci. USA. 93: 1097-1102.
18. Mehta, A., and D. M. Driscoll. 1998. A sequence-specific RNA-binding protein complements apobec1 to edit apolipoprotein B mRNA. Mol. Cell. Biol. 18: 4426-4432.
19. Teng, B-B., S. Blumenthal, T. Forte, N. Navaratnam, J. Scott, A. M. Gotto, Jr., and L. Chan. 1994. Adenovirus-mediated gene transfer of rat apoB mRNA editing protein in mice virtually eliminates apoB-100 and normal LDL production. J. Biol. Chem. 269: 29395-29404.
20. Teng, B-B., B. Ishida, T. M. Forte, S. Blumenthal, L-Z. Song, A. M. Gotto, Jr., and L. Chan. 1997. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of apoB mRNA editing enzyme (apobec1). Arterioscler. Thromb. Vasc. Biol. 17: 889-897.
21. Kozarsky, K. F., D. K. Bonen, F. Giannoni, T. Funahashi, J. M. Wilson, and N. O. Davidson. 1996. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum. Gene Ther. 7: 943-957.
22. Hughes, S. D., D. Rouy, N. Navaratnam, J. Scott, and E. M. Rubin. 1996. Gene transfer of cytidine deaminase apobec1 lowers lipoprotein[a] in transgenic mice and induces apolipoprotein B editing in rabbits. Hum. Gene Ther. 7: 39-49.
23. Greeve, J., V. K. Jona, N. R. Chowdhury, M. Horwitz, and J. R. Chowdhury. 1996. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and Watanabe heritable hyperlipidemic rabbits. J. Lipid Res. 37: 2001-2017.
24. Funahashi, T., F. Giannoni, A. M. DePaoli, S. F. Skarosi, and N. O. Davidson. 1995. Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing. J. Lipid Res. 36: 414-428.
25. Nakamuta, M., K. Oka, J. Krushkal, K. Kobayashi, M. Yamamoto, W-H. Li, and L. Chan. 1995. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA editing protein (apobec1) gene in mice. J. Biol. Chem. 270: 13042-13056.
26. Hadjiagapiou, C., F. Giannoni, T. Funahashi, S. F. Skarosi, and N. O. Davidson. 1994. Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein. Nucleic Acids Res. 22: 1874-1879.
27. Lau, P. P., H-J. Zhu, A. Baldini, C. Charnsangavej, and L. Chan. 1994. Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc. Natl. Acad. Sci. USA. 91: 8522-8526.
28. Anant, S., A. J. MacGinnitie, and N. O. Davidson. 1995. Apobec1, the catalytic subunit of the mammalian apoB mRNA editing enzyme, is a novel RNA binding protein. J. Biol. Chem. 270: 14762-14767.
29. Navaratnam, N., S. Bhattacharya, T. Fujino, D. Patel, A. L. Jarmuz, and J. Scott. 1995. Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell. 81: 187-195.
30. MacGinnitie, A. J., S. Anant, and N. O. Davidson. 1995. Mutagenesis of apobec1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J. Biol. Chem. 270: 14768-14775.
31. Yang, Y., Y. Yang, K. Kovalski, and H. C. Smith. 1997. Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through apobec1 affinity chromatography. J. Biol. Chem. 272: 27700-27706.
32. Field, J., J. I. Nikawa, D. Broek, B. MacDonald, L. Rodgers, I. A. Wilson, R. A. Lernee, and M. Wigler. 1988. Purification of a Rasresponsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8: 2159-2165.
33. Chan, L., and B. B. Teng. 1996. Mammalian RNA editing. Hum. Mol. Genet. 8: 335-347.
34. Spotts, G. D., S. V. Patel, Q. Xiao, and S. R. Hann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17: 1459-1468.
35. Chou, P. Y., and G. D. Fasman. 1974. Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins. Biochemistry. 13: 211-222.
36. Chou, P. Y, and G. D. Fasman. 1978. Empirical predictions of protein conformation. Annu. Rev. Biochem. 47: 251-276.
37. Garnier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120: 97-120.
38. Garnier, J., J. F. Gibrat, and B. Robson. 1996. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol. 266: 540-553.
39. Nishikawa, K. 1983. Assessment of secondary-structure prediction of proteins comparison of computerized chou-fasman method with others. Biochim. Biophys. Acta. 748: 285-299.
40. Matsuo, Y., and K. Nishikawa. 1995. Assessment of a protein fold recognition method that takes into account four physicochemical properties: side-chain packing, solvation, hydrogen-bonding, and local conformation. Proteins. 23: 370-375.
41. Jameson, B. A., and H. Wolf. 1988. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput. Appl. Biosci. 4: 181-186.
42. Oka, K., K. Kobayashi, M. Sullivan, J. Martinez, B-B. Teng, K. Ishimura-Oka, and L. Chan. 1997. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant apobec1 leads to increase LDL in mice. J. Biol. Chem. 272: 1456-1460.
43. Scott, J., N. Navaratnam, S. Bhattacharya, and J. R. Morrison. 1994. The apolipoprotein B mRNA editing enzyme. Curr. Opin. Lipidol. 5: 87-93.
44. Roth, G. J. 1991. Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood. 77: 5-19.
45. Ransone, L. J., J. Visvader, P. Sassone-Corsi, and I. M. Verma. 1989. Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins. Genes & Dev. 3: 770-781.
46. De Serio, A., R. Graziani, R. Laufer, G. Ciliberto, and G. Paonessa. 1995. In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex. J. Mol. Biol. 254: 795-800.
47. Gimona, M., A. Watakabe, and D. M. Helfman. 1995. Specificity of dimer formation in tropomyosins: influence of alternatively spliced exons on homodimer and heterodimer assembly. Proc. Natl. Acad. Sci. USA. 92: 9776-9780.
48. Chen, M-R., J. M. Middeldorp, and D. Hayward. 1993. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67: 4875-4885.
49. Shuman, J. D., J. Cheong, and J. E. Coligan. 1997. ATF-2 and C/ EBP can form a heterodimeric DNA binding complex in vitro. J. Biol. Chem. 272: 12793-12800.
50. Inukai, T., T. Inaba, T. Yoshihara, and A. T. Look. 1997. Cell transformation mediated by homodimeric E2A-HLF transcription factors. Mol. Cell. Biol. 17:1417-1424.
51. Dang, C. V., J. Barrett, M. Villa-Garcia, L. M. S. Resar, G. J. Kato, and E. R. Fearon. 1991. Intracellular leucine zipper interactions suggest c-myc hetero-oligomerization. Mol. Cell. Biol. 11: 954-962.
52. Fagan, R., K. J. Flint, and N. Jones. 1994. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19-kDa protein. Cell. 78: 799-811.
53. Robbins, J., S. M. Dilworth, R. A. Larskey, and C. Dingwall. 1991. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell. 64: 615-623.
54. Lukas, T. J., W. H. Burgess, F. G. Prendergast, W. Lau, and D. M. Watterson. 1986. Calmodulin binding domains: characterization of a phosphorylation and calmodulin binding site from myosin light chain kinase. Biochemistry. 25: 1458-1464.
55. Kemp, B. E., R. B. Pearson, V. J. Guereiero, I. C. Bagchi, and A. R. Means. 1987. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence. J. Biol. Chem. 262: 2542-2548.
56. Meador, W. E., A. R. Means, and F. A. Quiocho. 1992. Target enzyme recognition by calmodulin: 2.4A structure of a calmodulin-peptide complex. Science. 257: 1251-1255.
57. Ghou, P. Y., and G. D. Fasman. 1973. Structural and functional role of leucine residues in proteins. J. Mol. Biol. 74: 263-281.
58. Yang, Y., Y. Yang, and H. C. Smith. 1997. Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing. Proc. Natl. Acad. Sci. USA. 94: 13075-13080.
59. Betts, L., S. Xiang, S. A. Short, W. Richard, and C. W. J. Carter. 1994. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. J. Mol. Biol. 235: 635-656.
60. Bhattacharya, S., N. Navaratnam, J. R. Morrison, and J. Scott. 1994. Cytosine nucleoside/nucleotide deaminases and apolipoprotein mRNA editing. TIBS. 19: 105-106.
61. Navaratnam, N., T. Fujino, J. Bayliss, A. Jarmuz, A. How, N. Richardson, A. Somasekaram, S. Bhattacharya, C. Carter, and J. Scott. 1998. Escherichia coli cytidine deaminase provides a molecular model for apoB RNA editing and a mechanism for RNA substrate recognition. J. Mol. Biol 275: 695-714.
62. Greeve, J., H. Lellek, P. Rautenberg, and H. Greten. 1998. Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes. Biol. Chem. 379: 1063-1073.